Founder & President
Name to be confirmed
Founder biography pending confirmation.
About AXIONOVA™
Precision
bio-science
and longevity
infrastructure.
AXIONOVA™ builds governed bio-science infrastructure for responsible human optimization, connecting compounded medications, biometric devices, protocol operations, and molecular research under one accountable architecture.
Compound Identities
30
Biological Systems
10
Connected Components
14
Platform Posture
Physician-Directed, Prescription-Required
Hi, I am ALETHA. I help you understand your data and prepare it for your practitioner. I do not make clinical decisions; your practitioner does.
ALETHRA™ governs; ALETHA™ guides. About ALETHRA™
Intelligence in motion5 intelligence domains
AnalyzingEvaluating HRV trend · ECG rhythm → autonomic-load context
Consent Protocol Record Ring & Bracelet Trends AXIS Events Labs
Inputs · Ring·Bracelet
The Governed Model
One accountable
operating system.
AXIONOVA™ is not a single product. It is a governed environment that treats devices, compounds, protocols, and AI as one system. ALETHRA™ governs the system. ALETHA™ guides the experience. A licensed physician authorizes every clinical outcome.
How It Works
Observe. Analyze.
Execute. Refine.
Governed at every transition.
Biological research requires a closed loop. The AXIONOVA™ Ring and Bracelet capture physiological context, ALETHA™ routes findings for review, AXIS executes governed delivery, and ALETHRA™ refines the protocol record. No transition proceeds without authorization.
01ObserveThe AXIONOVA™ Ring and Bracelet capture source-labeled physiology.
02AnalyzeALETHA structures patterns for review.
03ExecuteAXIS records governed delivery events.
04RefineALETHRA integrates outcomes into protocol records.
Leadership & Oversight
The people and the oversight
model behind AXIONOVA™.
Built by people who care about getting this right. AXIONOVA™ is led by a named executive team and a licensed physician oversight function, supported by a research and advisory board. AXIONOVA™ operates binationally: the U.S. FDA as the primary commercial pathway and Mexico COFEPRIS as the home base for clinical deployment.
CEO
Name to be confirmed
Executive biography pending confirmation.
CMO / Physician Oversight Lead
Name to be confirmed
Medical license type and jurisdiction pending confirmation.
Chief Science Officer · ARCHE
Name to be confirmed
Molecular research credentials pending confirmation.
Board Advisor
Name to be confirmed
Advisor name and affiliation pending confirmation.
Board Advisor
Name to be confirmed
Advisor name and affiliation pending confirmation.
01ALETHA™ Prepares Context
02Physician Reviews, Edits, or Rejects
03Physician Authorizes
Physician-Directed Care · Human-in-the-Loop
All clinical decisions, diagnoses, and prescriptions are made by independent licensed physicians. AXIONOVA™ does not practice medicine. The autonomy is in the work; the authority stays human. A licensed physician reviews, edits, or rejects, and authorizes every clinical outcome, and every action is logged by ALETHRA™ for audit.
Two-Path Access
Request review for governed access.
Licensed practitioners apply directly through Path 1. Individuals and non-licensed applicants apply through Path 2 and are routed through AXIONOVA™’s on-staff doctors for telehealth oversight.